| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/31/2023 | 25.26% | Wedbush | → $48 | Reiterates | Outperform → Outperform |
| 08/24/2023 | 9.6% | KGI Securities | → $42 | Downgrades | Outperform → Neutral |
| 08/22/2023 | 20.04% | TD Cowen | $65 → $46 | Maintains | Market Perform |
| 08/22/2023 | 25.26% | Wedbush | → $48 | Initiates Coverage On | → Outperform |
| 08/18/2023 | 17.43% | JP Morgan | → $45 | Downgrades | Overweight → Neutral |
| 08/17/2023 | 67.01% | Barclays | $98 → $64 | Maintains | Overweight |
| 08/16/2023 | 30.48% | Citigroup | $98 → $50 | Downgrades | Buy → Neutral |
| 08/16/2023 | 67.01% | Barclays | $98 → $64 | Maintains | Overweight |
| 08/16/2023 | 82.67% | Bernstein | $90 → $70 | Maintains | Outperform |
| 08/16/2023 | 38.31% | B of A Securities | $73 → $53 | Maintains | Neutral |
| 07/31/2023 | 124.43% | UBS | $66 → $86 | Upgrades | Neutral → Buy |
| 05/17/2023 | 134.86% | B of A Securities | $92 → $90 | Maintains | Neutral |
| 05/17/2023 | 174.01% | Benchmark | → $105 | Reiterates | Buy → Buy |
| 05/17/2023 | 145.3% | HSBC | $92 → $94 | Maintains | Buy |
| 04/21/2023 | 174.01% | Benchmark | → $105 | Initiates Coverage On | → Buy |
| 04/20/2023 | 140.08% | UBS | $105 → $92 | Downgrades | Buy → Neutral |
| 04/13/2023 | 129.65% | Loop Capital | $62 → $88 | Maintains | Hold |
| 03/22/2023 | 160.96% | Bernstein | $80 → $100 | Maintains | Outperform |
| 03/08/2023 | 140.08% | B of A Securities | $68 → $92 | Maintains | Neutral |
| 03/08/2023 | 140.08% | HSBC | $87 → $92 | Maintains | Buy |
| 03/08/2023 | 200.1% | Jefferies | $104 → $115 | Maintains | Buy |
| 03/08/2023 | 67.01% | TD Cowen | $60 → $64 | Maintains | Market Perform |
| 03/08/2023 | 187.06% | Citigroup | $105 → $110 | Maintains | Buy |
| 01/09/2023 | 56.58% | B of A Securities | $74 → $60 | Downgrades | Buy → Neutral |
| 11/22/2022 | 56.58% | Cowen & Co. | $72 → $60 | Downgrades | Outperform → Market Perform |
| 11/17/2022 | 147.91% | Morgan Stanley | $116 → $95 | Maintains | Overweight |
| 11/17/2022 | 155.74% | Barclays | $100 → $98 | Maintains | Overweight |
| 11/16/2022 | 87.89% | Cowen & Co. | $78 → $72 | Maintains | Outperform |
| 11/16/2022 | 93.11% | B of A Securities | $86 → $74 | Maintains | Buy |
| 11/16/2022 | 153.13% | Citigroup | $129 → $97 | Maintains | Buy |
| 11/16/2022 | 95.72% | JP Morgan | $70 → $75 | Maintains | Overweight |
| 11/14/2022 | 103.55% | Cowen & Co. | $106 → $78 | Maintains | Outperform |
| 11/07/2022 | 82.67% | JP Morgan | → $70 | Upgrades | Neutral → Overweight |
| 10/28/2022 | 160.96% | Barclays | $114 → $100 | Maintains | Overweight |
| 08/18/2022 | 197.49% | Barclays | $125 → $114 | Maintains | Overweight |
| 08/17/2022 | 147.91% | Stifel | $105 → $95 | Maintains | Buy |
| 08/17/2022 | 236.64% | Citigroup | $145 → $129 | Maintains | Buy |
| 07/20/2022 | 226.2% | Barclays | $157 → $125 | Maintains | Overweight |
| 07/15/2022 | 174.01% | Stifel | $115 → $105 | Maintains | Buy |
| 05/19/2022 | 309.71% | Barclays | $201 → $157 | Maintains | Overweight |
| 05/18/2022 | 200.1% | Cowen & Co. | $133 → $115 | Maintains | Outperform |
| 05/18/2022 | 200.1% | Stifel | $160 → $115 | Maintains | Buy |
| 05/18/2022 | 395.82% | Goldman Sachs | $196 → $190 | Maintains | Buy |
| 04/27/2022 | 267.95% | CICC | → $141 | Initiates Coverage On | → Outperform |
| 04/26/2022 | 299.27% | China Renaissance | $156 → $153 | Maintains | Buy |
| 03/21/2022 | 291.44% | HSBC | $265 → $150 | Maintains | Buy |
| 03/04/2022 | 174.01% | JP Morgan | $250 → $105 | Downgrades | Overweight → Neutral |
| 03/03/2022 | 424.53% | Barclays | $218 → $201 | Maintains | Overweight |
| 02/14/2022 | 552.4% | JP Morgan | $420 → $250 | Maintains | Overweight |
| 02/07/2022 | 468.89% | Barclays | $427 → $218 | Maintains | Overweight |
| 01/27/2022 | 643.74% | Macquarie | $435 → $285 | Maintains | Outperform |
| 01/19/2022 | 395.82% | Loop Capital | → $190 | Initiates Coverage On | → Hold |
| 11/17/2021 | 891.65% | UBS | $350 → $380 | Maintains | Buy |
| 11/17/2021 | 904.7% | B of A Securities | $380 → $385 | Downgrades | Buy → Neutral |
| 11/03/2021 | 1014.3% | Barclays | → $427 | Initiates Coverage On | → Overweight |
| 09/29/2021 | 943.84% | DZ Bank | → $400 | Initiates Coverage On | → Buy |
| 09/15/2021 | 943.84% | Stifel | $325 → $400 | Upgrades | Hold → Buy |
| 08/16/2021 | 800.31% | Cowen & Co. | $280 → $345 | Maintains | Outperform |
| 07/22/2021 | 735.07% | Morgan Stanley | $300 → $320 | Maintains | Overweight |
| 06/25/2021 | 748.12% | New Street Research | → $325 | Initiates Coverage On | → Buy |
| 06/16/2021 | — | Bernstein | Initiates Coverage On | → Outperform | |
| 06/10/2021 | 787.27% | B of A Securities | $260 → $340 | Upgrades | Neutral → Buy |
| 04/20/2021 | 886.43% | Autonomous Research | → $378 | Initiates Coverage On | → Outperform |
| 03/29/2021 | 617.64% | CLSA | → $275 | Upgrades | Outperform → Buy |
| 03/08/2021 | 630.69% | Macquarie | → $280 | Upgrades | Neutral → Outperform |
| 03/03/2021 | 578.5% | Stifel | $225 → $260 | Maintains | Hold |
| 02/23/2021 | 735.07% | Cowen & Co. | $225 → $320 | Maintains | Outperform |
| 11/18/2020 | 354.07% | B of A Securities | $164 → $174 | Reiterates | → Neutral |
| 11/11/2020 | 327.97% | B of A Securities | → $164 | Downgrades | Buy → Neutral |
| 10/06/2020 | 421.92% | UBS | → $200 | Initiates Coverage On | → Buy |
| 08/20/2020 | 377.56% | DBS Bank | $72.5 → $183 | Upgrades | Sell → Buy |
| 07/08/2020 | 252.3% | B of A Securities | $69.5 → $135 | Reiterates | → Buy |
| 07/01/2020 | 239.25% | Stephens & Co. | → $130 | Initiates Coverage On | → Overweight |
| 05/15/2020 | 61.8% | Stifel | $55 → $62 | Downgrades | Buy → Hold |
| 03/04/2020 | 43.53% | Stifel | $50 → $55 | Maintains | Buy |
| 01/22/2020 | 30.48% | Goldman Sachs | $42.5 → $50 | Maintains | Buy |
| 11/07/2019 | 4.38% | Stifel | $45 → $40 | Maintains | Buy |
| 08/28/2019 | — | CLSA | Upgrades | Outperform → Buy | |
| 08/21/2019 | 17.43% | Stifel | $44 → $45 | Maintains | Buy |
| 08/08/2019 | 12.21% | Piper Sandler | $35 → $43 | Maintains | Overweight |
| 08/06/2019 | 2.04% | CLSA | → $39.1 | Downgrades | Buy → Outperform |
| 06/13/2019 | -6.05% | JP Morgan | → $36 | Initiates Coverage On | → Overweight |
What is the target price for Sea (SE)?
The latest price target for Sea (NYSE: SE) was reported by Wedbush on August 31, 2023. The analyst firm set a price target for $48.00 expecting SE to rise to within 12 months (a possible 25.26% upside). 34 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sea (SE)?
The latest analyst rating for Sea (NYSE: SE) was provided by Wedbush, and Sea reiterated their outperform rating.
When is the next analyst rating going to be posted or updated for Sea (SE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sea, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sea was filed on August 31, 2023 so you should expect the next rating to be made available sometime around August 31, 2024.
Is the Analyst Rating Sea (SE) correct?
While ratings are subjective and will change, the latest Sea (SE) rating was a reiterated with a price target of $0.00 to $48.00. The current price Sea (SE) is trading at is $38.32, which is within the analyst's predicted range.